FDA issued a Warning Letter to Megafine Pharma Limited on 5/19/2016 as a result of this inspection.
483 Megafine Pharma (P) May 2015

483 Megafine Pharma (P) May 2015

Ademola Daramola FDA$119.00 - Available Now

FDA investigators audited the Megafine Pharma (P) - Lakhamapur, India facility and issued 3 inspectional observations (via FDA 483) on 15 May 2015.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Number of Observations: 3
  • Inspection end: 15 May 2015
  • Location: Lakhamapur, India
  • FEI: 3005694111
Add To Cart